AGM/EGMApr 29, 2026, 04:19 PM
DMRA to hold 2026 Annual Meeting on June 17; Elects 2 Directors
AI Summary
Damora Therapeutics, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on Wednesday, June 17, 2026, at 9:00 a.m. Eastern Time. Stockholders of record as of April 22, 2026, are eligible to vote on proposals including the election of two Class III directors, advisory votes on executive compensation and its frequency, and the ratification of Ernst & Young LLP as the independent auditor. The company also noted its name change from Galecto, Inc. to Damora Therapeutics, Inc. on March 10, 2026, following an acquisition in November 2025.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 17, 2026, at 9:00 a.m. ET.
- Record date for voting is April 22, 2026.
- Stockholders to vote on election of two Class III directors.
- Advisory vote on named executive officer compensation.
- Advisory vote on frequency of future executive compensation votes.
- Ratification of Ernst & Young LLP as independent auditor for 2026.
- Company changed name to Damora Therapeutics, Inc. on March 10, 2026.
- Acquired Damora Therapeutics, Inc. on November 10, 2025.
Price Impact
More from DMRA